Emergency Department Initiated Tobacco Treatment (EDITT)
| Status: | Completed |
|---|---|
| Conditions: | Smoking Cessation, Hospital |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases, Other |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 1/12/2017 |
| Start Date: | December 2005 |
| End Date: | December 2007 |
The primary purpose of the study is to refine the intervention protocols for two
ED-initiated tobacco interventions and to assess the magnitude of the effect size that can
be expected. We expect the intervention groups to have greater sustained abstinence,
point-prevalence abstinence, and motivation to change when compared to the treatment as
usual group at 1- and 3-month follow-up.
ED-initiated tobacco interventions and to assess the magnitude of the effect size that can
be expected. We expect the intervention groups to have greater sustained abstinence,
point-prevalence abstinence, and motivation to change when compared to the treatment as
usual group at 1- and 3-month follow-up.
Most surveys of emergency physicians indicate that smoking cessation counseling rarely
occurs in routine clinical practice. Prochazka and colleagues (1996) studied 196 members of
the Colorado Chapter of the American College of Emergency Physicians and found that only 27%
reported routinely asking patients to quit smoking. We conducted a similar survey study and
found that only 19% of emergency physicians practicing in an urban teaching hospital
reported that they routinely counseled their tobacco using patients to quit. A study of 63
adult smokers presenting to the ED with symptoms of acute respiratory illness found that
only 9% were offered any assistance with quitting (Bock et al., 2001). Clearly, more
research was needed to investigate smoking interventions initiated in the ED.
Currently, not much is known about how best to intervene with smokers in the ED. This
proposal describes a pilot study designed to explore two interventions. Research that
expands our knowledge of ED-initiated tobacco interventions has tremendous public health
potential, especially for the under-served populations that are over-represented in the ED
patient population.This study is designed primarily to yield effects size parameters so a
larger RCT can be planned. For this reason, it is not powered specifically to detect a given
difference, but, rather, simply to provide an idea of the size of the effect so we can
determine how many subjects would be needed in a future trial in order to demonstrate
statistical significance and clinical utility. It will also be used to refine the study
design, protocols, and treatment manuals for the future trial.
This study will be a randomized, single-blind, controlled trial that will compared two types
of ED-initiated tobacco treatment to treatment-as-usual. 75 ED patients who meet all
inclusion and exclusion criteria will be randomly assigned to one of three groups using a
2:2:1 ratio: Group One: Enhanced Care (n=30), Group Two: Dynamic Referral (n=30), or Group
Three: Clinic Referral (n=15). This assignment ratio is being used to maximize experience
with the treatments. The two interventions will be delivered by trained counselors and are
described below. Baseline measures of smoking and other related variables will be taken
during the ED visit. An interviewer blind to study group assignment will conduct follow-up
assessments via telephone at 1- and 3-months after the ED visit. We expect a 25% attrition,
yielding follow-up data at 3-months on 23, 23, and 11 patients, respectively, for each
Group.
Primary outcomes will include: sustained abstinence from the ED visit to the follow-up time
periods and 7-day point prevalence abstinence. Secondary outcomes will be: presence of a
quit attempt >= 24 hours and readiness to change.
occurs in routine clinical practice. Prochazka and colleagues (1996) studied 196 members of
the Colorado Chapter of the American College of Emergency Physicians and found that only 27%
reported routinely asking patients to quit smoking. We conducted a similar survey study and
found that only 19% of emergency physicians practicing in an urban teaching hospital
reported that they routinely counseled their tobacco using patients to quit. A study of 63
adult smokers presenting to the ED with symptoms of acute respiratory illness found that
only 9% were offered any assistance with quitting (Bock et al., 2001). Clearly, more
research was needed to investigate smoking interventions initiated in the ED.
Currently, not much is known about how best to intervene with smokers in the ED. This
proposal describes a pilot study designed to explore two interventions. Research that
expands our knowledge of ED-initiated tobacco interventions has tremendous public health
potential, especially for the under-served populations that are over-represented in the ED
patient population.This study is designed primarily to yield effects size parameters so a
larger RCT can be planned. For this reason, it is not powered specifically to detect a given
difference, but, rather, simply to provide an idea of the size of the effect so we can
determine how many subjects would be needed in a future trial in order to demonstrate
statistical significance and clinical utility. It will also be used to refine the study
design, protocols, and treatment manuals for the future trial.
This study will be a randomized, single-blind, controlled trial that will compared two types
of ED-initiated tobacco treatment to treatment-as-usual. 75 ED patients who meet all
inclusion and exclusion criteria will be randomly assigned to one of three groups using a
2:2:1 ratio: Group One: Enhanced Care (n=30), Group Two: Dynamic Referral (n=30), or Group
Three: Clinic Referral (n=15). This assignment ratio is being used to maximize experience
with the treatments. The two interventions will be delivered by trained counselors and are
described below. Baseline measures of smoking and other related variables will be taken
during the ED visit. An interviewer blind to study group assignment will conduct follow-up
assessments via telephone at 1- and 3-months after the ED visit. We expect a 25% attrition,
yielding follow-up data at 3-months on 23, 23, and 11 patients, respectively, for each
Group.
Primary outcomes will include: sustained abstinence from the ED visit to the follow-up time
periods and 7-day point prevalence abstinence. Secondary outcomes will be: presence of a
quit attempt >= 24 hours and readiness to change.
Inclusion Criteria:
- 18 years old
- receiving treatment in the ED
- smoking at least 10 cigarettes daily
Exclusion Criteria:
- too ill to participate
- temporary shelter
- no phone
We found this trial at
1
site
Cooper University Hospital Cooper University Health Care, the clinical campus of Cooper Medical School of...
Click here to add this to my saved trials
